A clinical trial is ongoing to test if stem cells harvested from bone marrow and injected into an ALS (amyotrophic lateral sclerosis) patient’s spinal fluid will stop or slow the progression of ALS. ALS is a disease of the nervous system that affects a person’s ability to speak, eat, and eventually breathe. The therapy was developed by BrainStorm Cell Therapeutics and there are six locations across the United States testing the therapy.

Read the source article at The Boston Globe.

If you or a loved one suffers from ALS and would like to learn more and connect with others, click here.